tirzepatide weight gain NEW: Stopping (Mounjaro) leads patients to back the majority of lost weight. - Patients on tirzepatide lost 21% of their body in 36 months Tirzepatide Side Effects: Timeline, Symptoms,
Description
Mounjaro is a GLP-1 receptor agonist

But bananas back then were more like plantains, and not sweet

Tirzepatide is a 39-amino acid synthetic peptide with dual GLP-1/GIP receptor agonism

E.VendruscoloL

"Monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, and curcumin." Am J Hematol
